References
- Perez-Valero I, Arribas J. Protease inhibitor monotherapy. Curr Opin Infect Dis. 2011;24:7–11
- Arribas JR, Horban A, Gerstoft J, Fätkenheuer G, Nelson M, Clumeck N, et al.. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml. AIDS. 2010;24:223–30.
- Arribas JR, Delgado R, Arranz A, Munoz R, Portilla J, Pasquau J, et al.. Lopinavir-ritonavir monotherapy versus lopinavir–ritonavir and two nucleosides for maintenance therapy of HIV: 96-week analysis. J Acquir Immune Defic Syndr. 2009;51:147–52.
- Cahn P, Montaner J, Junod P, Patterson P, Krolewiecki A, Andrade-Villanueva J, et al.. Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen. PLoS One. 2011;6(8):e23726
- Bunupuradah T, Lumbiganon P, Puthanakit T, Ananworanich J, Mengthaisong T, Boonrak P, et al.. Simplifying antiretroviral treatment in virally suppressed children by switching from double boosted protease inhibitors to lopinavir/ritonavir monotherapy. Proceedings of the 5th IAS Conference on HIV Pathogenesis and Treatment; Cape Town, South Africa; 2009; abstract no. MOPEB062.
- Mur-Sierra A, López-Segura N, López-Vílchez MA. Simplification to lopinavir/ritonavir monotherapy in HIV-infected children. An Pediatr (Barc). 2011;75:51–4.
- McComsey GA, Leonard E. Metabolic complications of HIV therapy in children. AIDS. 2004;18:1753–68.
- Giordano TP, Guzman D, Clark R. Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials. 2004;5;74–9.
- Johnson VA, Brun-Vézinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, et al.. Antiretroviral drug resistance testing in adult HIV-1 infection — 2010 recommendations of an IAS–USA panel. Top HIV Med. 2010;18:156–63.
- Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, et al.. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virustype 1 from mother to child. N Engl J Med. 1996;335:1621–9.
- Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55:1–17.
- Cameron DW, da Silva BA, Arribas JR, Myers RA, Bellos NC, Gilmore N, et al.. A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy. J Infect Dis. 2008;198:234–40.